AFASCI INC has a total of 20 patent applications. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are Novogen ltd, NIVALIS THERAPEUTICS INC and CHANGZHOU JIEKAI PHARMATECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Hong Kong | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 | |
#12 | Philippines | 1 | |
#13 | Russian Federation | 1 | |
#14 | Singapore | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Xie Xinmin | 16 |
#2 | Kayser Frank | 12 |
#3 | Xinmin Xie | 4 |
#4 | Frank Kayser | 3 |
#5 | Maezawa Izumi | 2 |
#6 | Jin Lee-Way | 2 |
#7 | Hua Duy H | 2 |
#8 | Xie Xi | 1 |
#9 | Pascual Conrado | 1 |
#10 | Xie James | 1 |
Publication | Filing date | Title |
---|---|---|
US2020069665A1 | Methods of treating hypersensitive cough or itching using ion channel inhibitory compounds | |
WO2017083867A1 | Ion channel inhibitory compounds, pharmaceutical formulations and uses | |
US2016347810A1 | Compositions and methods for treating acute and chronic pain by local antagonism of CGRP receptors, or combination with sodium channel inhibition or with anti-inflammatory agents | |
US2015119406A1 | Tricyclic pyrone compounds reduce amyloid beta aggregates |